42 U.S.C. § 1395iii (THE PUBLIC HEALTH AND WELFARE)
§ 1395iii. Medicare Improvement Fund
(a) Establishment
The Secretary shall establish under this subchapter a Medicare Improvement Fund (in this section referred to as the “Fund”) which shall be available to the Secretary to make improvements under the original Medicare fee-for-service program under parts A and B for individuals entitled to, or enrolled for, benefits under part 1 or enrolled under part B including adjustments to payments for items and services furnished by providers of services and suppliers under such original Medicare fee-for-service program.
(b) Funding
(1) In general
There shall be available to the Fund, for expenditures from the Fund for services furnished during and after fiscal year 2020, $0.2
(2) Payment from Trust Funds
The amount specified under paragraph (1) shall be available to the Fund, as expenditures are made from the Fund, from the Federal Hospital Insurance Trust Fund and the Federal Supplementary Medical Insurance Trust Fund in such proportion as the Secretary determines appropriate.
(3) Funding limitation
Amounts in the Fund shall be available in advance of appropriations but only if the total amount obligated from the Fund does not exceed the amount available to the Fund under paragraph (1). The Secretary may obligate funds from the Fund only if the Secretary determines (and the Chief Actuary of the Centers for Medicare & Medicaid Services and the appropriate budget officer certify) that there are available in the Fund sufficient amounts to cover all such obligations incurred consistent with the previous sentence.
(4) No effect on payments in subsequent years
In the case that expenditures from the Fund are applied to, or otherwise affect, a payment rate for an item or service under this subchapter for a year, the payment rate for such item or service shall be computed for a subsequent year as if such application or effect had never occurred.
(Aug. 14, 1935, ch. 531, title XVIII, § 1898, as added Pub. L. 110–252, title VII, § 7002(a), June 30, 2008, 122 Stat. 2394; amended Pub. L. 110–275, title I, § 188(a)(2)(B), July 15, 2008, 122 Stat. 2589; Pub. L. 110–379, § 6, Oct. 8, 2008, 122 Stat. 4079; Pub. L. 111–5, div. B, title IV, § 4103(b), Feb. 17, 2009, 123 Stat. 487; Pub. L. 111–118, div. B, § 1011(b), Dec. 19, 2009, 123 Stat. 3474; Pub. L. 111–148, title III, § 3112, Mar. 23, 2010, 124 Stat. 421; Pub. L. 111–309, title II, § 207, Dec. 15, 2010, 124 Stat. 3291; Pub. L. 112–240, title VI, § 640, Jan. 2, 2013, 126 Stat. 2357; Pub. L. 113–82, § 3, Feb. 15, 2014, 128 Stat. 1009; Pub. L. 113–93, title II, § 219, Apr. 1, 2014, 128 Stat. 1070; Pub. L. 113–185, § 3(e), Oct. 6, 2014, 128 Stat. 1969; Pub. L. 114–10, title V, § 518, Apr. 16, 2015, 129 Stat. 175; Pub. L. 114–60, § 2(c), Oct. 7, 2015, 129 Stat. 544; Pub. L. 114–113, div. O, title V, § 501, Dec. 18, 2015, 129 Stat. 3018; Pub. L. 114–115, § 5, Dec. 28, 2015, 129 Stat. 3133; Pub. L. 114–198, title VII, § 704(h), July 22, 2016, 130 Stat. 752; Pub. L. 114–255, div. A, title V, § 5001, Dec. 13, 2016, 130 Stat. 1188; Pub. L. 115–63, title III, § 303, Sept. 29, 2017, 131 Stat. 1172.)
heading: Amendment of Subsection (b)(1)
text: Pub. L. 115–63, title III, § 303, Sept. 29, 2017, 131 Stat. 1172, provided that subsection (b)(1) of this section is amended by striking “during and after fiscal year 2021, $270,000,000” and inserting “during and after fiscal year 2021, $220,000,000”. See 2017 Amendment note below.
Pub. L. 114–255, div. A, title V, § 5001, Dec. 13, 2016, 130 Stat. 1188, provided that subsection (b)(1) of this section, as amended by section 704(h) of Pub. L. 114–198, is amended by striking “$140,000,000” and inserting “$270,000,000”.
Pub. L. 114–198, title VII, § 704(g)(1), (h), July 22, 2016, 130 Stat. 751, 752, provided that, applicable to prescription drug plans (and MA–PD plans) for plan years beginning on or after Jan. 1, 2019, subsection (b)(1) of this section is amended by striking “during and after fiscal year 2020, $0” and inserting “during and after fiscal year 2021, $140,000,000”.
See 2016 Amendment notes below.
heading: Amendments
text: 2017—Subsec. (b)(1). Pub. L. 115–63 substituted “during and after fiscal year 2021, $220,000,000” for “during and after fiscal year 2021, $270,000,000”.
2016—Subsec. (b)(1). Pub. L. 114–255 substituted “$270,000,000” for “$140,000,000”.
Pub. L. 114–198 substituted “during and after fiscal year 2021, $140,000,000” for “during and after fiscal year 2020, $0”.
2015—Subsec. (b)(1). Pub. L. 114–115 substituted “$0” for “$5,000,000”.
Pub. L. 114–113 substituted “$5,000,000” for “$205,000,000”.
Pub. L. 114–60 substituted “$205,000,000” for “$0”.
Pub. L. 114–10 substituted “$0” for “$195,000,000”.
2014—Pub. L. 113–185, § 3(e)(1), substituted “Medicare Improvement Fund” for “Transitional Fund for Sustainable Growth Rate (SGR) Reform” in section catchline.
Pub. L. 113–82, § 3(1), substituted “Transitional Fund for Sustainable Growth Rate (SGR) Reform” for “Medicare Improvement Fund” in section catchline.
Subsec. (a). Pub. L. 113–185, § 3(e)(2), amended subsec. (a) generally. Prior to amendment, text read as follows: “The Secretary shall establish under this subchapter a Transitional Fund for Sustainable Growth Rate (SGR) Reform (in this section referred to as the ‘Fund’) which shall be available to the Secretary to provide funds to pay for physicians’ services under part B to supplement the conversion factor under section 1395w–4(d) of this title for 2017 if the conversion factor for 2017 is less than conversion factor for 2013.”
Pub. L. 113–82, § 3(2), amended subsec. (a) generally. Prior to amendment, text read as follows: “The Secretary shall establish under this subchapter a Medicare Improvement Fund (in this section referred to as the ‘Fund’) which shall be available to the Secretary to make improvements under the original medicare fee-for-service program under parts A and B for individuals entitled to, or enrolled for, benefits under part A or enrolled under part B including, but not limited to, an increase in the conversion factor under section 1395w–4(d) of this title to address, in whole or in part, any projected shortfall in the conversion factor for 2014 relative to the conversion factor for 2008 and adjustments to payments for items and services furnished by providers of services and suppliers under such original medicare fee-for-service program.”
Subsec. (b)(1). Pub. L. 113–185, § 3(e)(3), substituted “during and after fiscal year 2020, $195,000,000.” for “during or after 2017, $0.”
Pub. L. 113–93 substituted “$0” for “$2,300,000,000”.
Pub. L. 113–82, § 3(3), substituted “during or after 2017, $2,300,000,000.” for “during—
“(A) fiscal year 2014, $0; and
“(B) fiscal year 2015, $0.”
Subsec. (b)(2). Pub. L. 113–185, § 3(e)(4), substituted “from the Federal Hospital Insurance Trust Fund and the Federal Supplementary Medical Insurance Trust Fund in such proportion as the Secretary determines appropriate.” for “from the Federal Supplementary Medical Insurance Trust Fund.”
Pub. L. 113–82, § 3(4), substituted “from the Federal Supplementary Medical Insurance Trust Fund.” for “from the Federal Hospital Insurance Trust Fund and the Federal Supplementary Medical Insurance Trust Fund in such proportion as the Secretary determines appropriate.”
2013—Subsec. (b)(1). Pub. L. 112–240 added subpars. (A) and (B) and struck out former subpars. (A) to (C) which read as follows:
“(A) fiscal year 2014, $0;
“(B) fiscal year 2015, $275,000,000; and
“(C) fiscal year 2020 and each subsequent fiscal year, the Secretary’s estimate, as of July 1 of the fiscal year, of the aggregate reduction in expenditures under this subchapter during the preceding fiscal year directly resulting from the reduction in payment amounts under sections 1395w–4(a)(7), 1395w–23(l)(4), 1395w–23(m)(4), and 1395ww(b)(3)(B)(ix) of this title.”
2010—Subsec. (b)(1)(A). Pub. L. 111–148, which directed substitution of “$0” for “$22,290,000,000”, was executed by making the substitution for “$20,740,000,000” to reflect the probable intent of Congress and the intervening amendment by Pub. L. 111–118, § 1011(b)(1)(A). See 2009 Amendment note below.
Subsec. (b)(1)(B). Pub. L. 111–309 substituted “$275,000,000” for “$550,000,000”.
2009—Subsec. (a). Pub. L. 111–5, § 4103(b)(1), inserted “medicare” before “fee-for-service program under” and “including, but not limited to, an increase in the conversion factor under section 1395w–4(d) of this title to address, in whole or in part, any projected shortfall in the conversion factor for 2014 relative to the conversion factor for 2008 and adjustments to payments for items and services furnished by providers of services and suppliers under such original medicare fee-for-service program” before period at end.
Subsec. (b)(1). Pub. L. 111–5, § 4103(b)(2)(A), substituted “during—” for “during fiscal year 2014, $2,290,000,000 and, in addition for services furnished during fiscal years 2014 through 2017, $19,900,000,000.” and added subpars. (A) and (B).
Subsec. (b)(1)(A). Pub. L. 111–118, § 1011(b)(1)(A), substituted “$20,740,000,000” for “$22,290,000,000”.
Subsec. (b)(1)(B), (C). Pub. L. 111–118, § 1011(b)(1)(B)–(3), added subpar. (B) and redesignated former subpar. (B) as (C).
Subsec. (b)(4). Pub. L. 111–5, § 4103(b)(2)(B), added par. (4).
2008—Subsec. (b)(1). Pub. L. 110–379 substituted “$2,290,000,000” for “$2,220,000,000”.
Pub. L. 110–275 inserted “and, in addition for services furnished during fiscal years 2014 through 2017, $19,900,000,000” before period at end.
heading: Effective Date of 2016 Amendment
text: Amendment by Pub. L. 114–198 applicable to prescription drug plans (and MA–PD plans) for plan years beginning on or after January 1, 2019, see section 704(g)(1) of Pub. L. 114–198, set out as a note under section 1395w–101 of this title.